The Kratom Conundrum: Did Lobbying Influence Trump’s Opioid Policy U-Turn?
The Trump administration backed off a full ban on MGPI, a potent opioid compound found in some kratom products, and proposed allowing levels that HHS and the DEA have not found safe. A published New York Times investigation found the reversal followed industry lobbying and millions in Republican donations from a kratom executive whose company […]
Could Nigeria’s New Student Drug Testing Policy Be a Double-Edged Sword?
The Nigerian government has implemented mandatory drug testing for secondary and higher education students. Although the policy promises prevention and treatment, advocacy groups warn of the risks of exclusion and stigmatization, as well as a lack of rehabilitation resources. Could a policy meant to address adolescent drug use end up keeping young people out of […]
Former Staffer At Top Marijuana Policy Group Criticizes Its Push To Keep Hemp THC Products Legal (Op-Ed)
“The charade of hemp intoxicants must end. Sneaking in the back door with synthetic drugs nobody asked for is not the path to legalization.” By Chris Lindsey, American Trade Association for Cannabis and Hemp Last week, the Marijuana Policy Project (MPP) asked its supporters to urge Congress to keep intoxicating hemp products on the market. […]
Rhode Island Grapples With Hemp Policy As Federal Ban On THC Products Looms
“We kind of have to wait and see what the federal government does before we can…advise our licensees.” By Christopher Shea, Rhode Island Current On less than an acre of farmland in Hopkinton, rows of hemp plants were nearing harvest. Most of their “colas”—dense clusters of buds prized for smokable flower—had already been cut ahead […]


